These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28353372)

  • 1. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation.
    Contreras Muruaga MDM; Vivancos J; Reig G; González A; Cardona P; Ramírez-Moreno JM; Martí J; Suárez Fernández C;
    J Comp Eff Res; 2017 Jun; 6(4):303-312. PubMed ID: 28353372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study].
    Suárez C; Pose A; Montero-Pérez-Barquero M; Roquer J; Gállego J; Ràfols C; Cazorla D; Vivancos J;
    Med Clin (Barc); 2016 Sep; 147(5):192-198. PubMed ID: 27423653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of Patients Regarding Burdens and Benefits of Vitamin K Antagonists Among Patients with Nonvalvular Atrial Fibrillation.
    Escobar C; Barrios V; Prieto L; Lobos JM; Polo J; Vargas D
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):106-113. PubMed ID: 29879893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].
    Fareau S; Baumstarck K; Farcet A; Molines C; Auquier P; Retornaz F
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Mar; 13(1):45-54. PubMed ID: 25786423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-Related Quality of Life and Satisfaction in Atrial Fibrillation Patients on Anticoagulant Therapy: Differences between Vitamin K Antagonists and Direct Oral Anticoagulants; Results from the Multicentre REGUEIFA Registry.
    Cabanas-Grandío P; González-Melchor L; Caamaño MV; Windcheid EF; Babarro EG; Bobín OD; Portela MP; Delgado OP; Teja JE; Feijoo MG; Freire E; Castro OD; García JM; García-Seara J; González-Juanatey C
    J Clin Med; 2024 Sep; 13(17):. PubMed ID: 39274496
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.
    Mostaza JM; Suarez C; Cepeda JM; Manzano L; Sánchez D;
    BMC Cardiovasc Disord; 2021 Aug; 21(1):384. PubMed ID: 34372782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study.
    Lee YS; Oh YS; Choi EK; Chern AKC; Jiampo P; Chutinet A; Hanafy DA; Trivedi P; Zhai D
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34857666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status.
    Varona JF; Seguí-Ripoll JM; Lozano-Duran C; Cuadrado-Gómez LM; Montagud-Moncho JB; Ramos-Guerrero A; Mirete-Ferrer JC; Donado E; García-Alegría J;
    Health Qual Life Outcomes; 2020 Dec; 18(1):383. PubMed ID: 33308246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.
    Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.
    Kooistra HA; Piersma-Wichers M; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):388-94. PubMed ID: 27329860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with nonvalvular atrial fibrillation treated with oral anticoagulants.
    Gabilondo M; Loza J; Pereda A; Caballero O; Zamora N; Gorostiza A; Mar J
    Hematology; 2021 Dec; 26(1):277-283. PubMed ID: 33631081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.
    Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ikeya Y; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A;
    Int Heart J; 2018 Nov; 59(6):1266-1274. PubMed ID: 30369576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in Internal Medicine and Neurology departments of Spain].
    Reig-Rosello G; Contreras MM; Suarez-Fernandez C; Gonzalez-Hernandez A; Cardona P; Pons-Amate JM; Marti-Fabregas J; Vivancos J
    Rev Neurol; 2017 Oct; 65(8):361-367. PubMed ID: 28990646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction with oral anticoagulants in patients with atrial fibrillation.
    Suárez Fernández C; Castilla-Guerra L; Cantero Hinojosa J; Suriñach JM; Acosta de Bilbao F; Tamarit JJ; Diaz Diaz JL; Hernandez JL; Pose A; Montero-Pérez-Barquero M; Roquer J; Gállego J; Vivancos J; Mostaza JM
    Patient Prefer Adherence; 2018; 12():267-274. PubMed ID: 29497282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease.
    Douros A; Cui Y; Platt RW; Filion KB; Sebastiani G; Renoux C
    Br J Clin Pharmacol; 2022 Mar; 88(3):994-1009. PubMed ID: 34409636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.
    Barcellona D; Luzza M; Battino N; Fenu L; Marongiu F
    Intern Emerg Med; 2015 Mar; 10(2):157-63. PubMed ID: 25487958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.